Benefits Broker

Part of legislation created to keep the government from shutting down would require pharmacy benefit managers to pass all rebates on to the plan sponsors.

Although the GLP-1 drug Zepbound has been shown to be effective in promoting weight loss, availability and price have been barriers to more widespread use by patients.

Immediately, Trump's new Health appointees were met with a rash of strong reactions from assorted media outlets.

Two Competitive Enterprise Institute antitrust specialists say the agency never showed that PBMs are increasing patients' costs.

The three giants charge less than the guppies but report higher, more consistent profits, according to a new Health Affairs study.

Complex formulary structures, high initial pricing, entrenched market advantages favoring established brands, and hesitancy among prescribers and patients have slowed adoption, leaving billions in savings untapped.

CVS has been hit with at least three federal class actions, including two antitrust cases accusing CVS Caremark Corp. and other pharmacy benefit managers, the intermediaries between insurance companies and pharmacies, of price-fixing prescription drug reimbursement rates.

Plans in some markets cover a much higher percentage of the working-age population than in others.